Security Snapshot

GE HealthCare Technologies Inc. - Common Stock (GEHC) Institutional Ownership

CUSIP: 36266G107

13F Institutional Holders and Ownership History from Q2 2022 to Q3 2026

13F reference period

Q2 2026

Institutions Reporting

1,230

Shares (Excl. Options)

394.09MFull value: 394,085,390 · shares · 30 Jun 2026

Price

$64.01

The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0.01%
Share change
+4,082,128
Value change
+$178,243,936
Number of holders
1,230
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
450,800,552
SEC-reported price per share
$65.37
Insider filing price
$65.37
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • GEHC - GE HealthCare Technologies Inc. - Common Stock is tracked under CUSIP 36266G107.
  • 1230 institutions reported positions in Q2 2026.
  • 3 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 1,272 to 1,230 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from
    $27.74BFull value: $27,738,844,351 · USD · 31 Mar 2026
    to
    $25.24BFull value: $25,235,327,286 · USD · 30 Jun 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 1230 institutions filings for Q2 2026.

Open SEC evidence

Security key

36266G107

13F reference period

Q2 2026

13F holders

1,230

13D/G owners

3

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
3
Security
GEHC
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
DODGE & COX 10% +28% $3,091,387,328 +$618,478,777 47,334,058 +25% Dodge & Cox 31 Jul 2026
VANGUARD CAPITAL MANAGEMENT LLC 7.3% $2,375,284,501 33,370,111 Vanguard Capital Management 31 Mar 2026
Capital Research Global Investors 4.6% -15% $1,558,893,354 -$284,830,455 21,114,633 -15% Capital Research Global Investors 31 Mar 2026
As of 30 Jun 2026, 1,230 institutional investors reported holding
394.09MFull value: 394,085,390 · shares · 30 Jun 2026
shares of GE HealthCare Technologies Inc. - Common Stock (GEHC). This represents 87% of the company’s total
450.8MFull value: 450,800,552 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
63%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Dodge & Cox 8.4% 37,864,164 +21% 1.3% $2,423,685,138
BlackRock, Inc. 8.3% 37,467,843 +4.1% 0.04% $2,398,316,647
VANGUARD CAPITAL MANAGEMENT LLC 6.6% 29,724,359 +3% 0.04% $1,902,656,220
STATE STREET CORP 4.6% 20,861,566 +1.6% 0.04% $1,335,348,840
VANGUARD PORTFOLIO MANAGEMENT LLC 4.5% 20,275,526 +5.7% 0.06% $1,297,836,419
Invesco Ltd. 4.1% 18,296,350 +91% 0.09% $1,171,149,334
HARRIS ASSOCIATES L P 3.4% 15,329,664 -1.7% 1.3% $981,251,810
BARROW HANLEY MEWHINNEY & STRAUSS LLC 3% 13,455,814 +13% 2.6% $861,306,654
GEODE CAPITAL MANAGEMENT, LLC 2.9% 12,871,800 +3.8% 0.04% $820,819,153
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 2.7% 12,250,502 +23% 2.3% $784,154,633
JPMORGAN CHASE & CO 2.3% 10,329,164 +15% 0.04% $671,912,232
MORGAN STANLEY 1.4% 6,223,322 -6.3% 0.02% $398,355,059
NORGES BANK 1.3% 5,823,524 0.04% $372,763,771
DIMENSIONAL FUND ADVISORS LP 1.2% 5,401,410 +0.04% 0.06% $345,793,640
Boston Partners 1.1% 5,153,347 +1.1% 0.29% $329,829,280
VAN ECK ASSOCIATES CORP 0.99% 4,482,631 +4.1% 0.17% $286,933,211
GOLDMAN SACHS GROUP INC 0.99% 4,446,565 +36% 0.03% $284,624,656
NORTHERN TRUST CORP 0.87% 3,938,748 -2.8% 0.03% $252,119,259
LSV ASSET MANAGEMENT 0.77% 3,482,902 +92% 0.4% $222,941,000
BANK OF AMERICA CORP /DE/ 0.72% 3,249,771 -21% 0.01% $208,017,854
FMR LLC 0.7% 3,155,095 +14% 0.01% $201,957,622
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.69% 3,129,530 -0.87% 0.03% $200,321,215
TRIAN FUND MANAGEMENT, L.P. 0.68% 3,085,344 +76194% 4.7% $197,492,869
Legal & General Group Plc 0.61% 2,771,907 -4.2% 0.04% $177,429,770
Bank of New York Mellon Corp 0.59% 2,639,900 -6.4% 0.03% $168,979,994

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
18
Headline period
Q2 2026
Rows shown
1-18 of 18
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 13,993,410 $914,088,261 -$23,458,702 $65.37 385
2026 Q2 394,085,390 $25,235,327,286 +$178,243,936 $64.01 1,230
2026 Q1 389,890,630 $27,738,844,351 -$1,103,732,568 $71.18 1,272
2025 Q4 399,955,394 $32,801,357,254 +$1,786,054,534 $82.02 1,324
2025 Q3 377,725,286 $28,360,755,280 -$212,000,566 $75.10 1,261
2025 Q2 380,880,730 $28,208,807,389 +$393,834,208 $74.07 1,291
2025 Q1 374,829,803 $30,219,739,463 -$988,142,031 $80.71 1,347
2024 Q4 387,138,094 $30,283,860,637 +$226,612,753 $78.18 1,305
2024 Q3 378,461,668 $35,487,878,340 +$361,579,520 $93.85 1,252
2024 Q2 372,591,694 $29,028,206,077 +$168,669,463 $77.92 1,199
2024 Q1 370,025,533 $33,626,319,157 -$77,731,705 $90.91 1,233
2023 Q4 371,789,316 $28,744,260,126 +$196,826,949 $77.32 1,172
2023 Q3 367,999,106 $25,035,922,048 +$209,914,807 $68.04 1,086
2023 Q2 363,119,507 $29,492,432,114 -$702,805,941 $81.24 1,112
2023 Q1 371,671,811 $30,484,212,524 +$29,246,453,075 $82.03 1,045
2022 Q4 14,525,196 $848,721,223 +$848,465,237 $58.38 34
2022 Q3 0 $0 -$198,794 $65.37 0
2022 Q2 2,890 $234,558 +$198,794 $81.24 2
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .